Displaying 10 out of 4 results

  1. New Content Item

    Merck's Keytruda wins FDA approval as combination therapy for kidney cancer

    The U.S. Food and Drug Administration has approved Merck & Co Inc's cancer therapy, Keytruda, as part of a combination therapy for previously ...
  2. A logo of American pharmaceutical corporation Pfizer Inc., is pictured in Toluca

    Merck, Pfizer drug combo extends kidney cancer survival: study

    A combination of Merck & Co's immunotherapy Keytruda and Pfizer Inc's Inlyta helped patients with advanced kidney cancer live longer than those ...
  3. FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey

    Merck, Pfizer combo treatment meets main goals of kidney cancer trial

    Merck & Co said on Thursday a combination treatment of its cancer drug Keytruda and Pfizer Inc's Inlyta met the main goals of a late-stage study ...
  4. New Content Item

    Merck KGaA, Pfizer's immuno-drug shown to alleviate kidney cancer